Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,398.93
+0.8%
+61.82
Arrow-Thin-Down
DJI
49,609.16
+0.0%
+12.19
Arrow-Thin-Down
NASDAQ
26,247.08
+1.7%
+440.88
Arrow-Thin-Down
Bitcoin
$80,760.00
+0.1%
+$46.91
Arrow-Thin-Down
AAPL
$293.14
+2.1%
+$5.96
Arrow-Thin-Down
AMZN
$272.66
+0.5%
+$1.49
Arrow-Thin-Down
GOOG
$396.94
+0.4%
+$1.64
Arrow-Thin-Down
META
$609.53
-1.2%
-$7.28
Arrow-Thin-Down
MSFT
$415.17
-1.3%
-$5.60
Arrow-Thin-Down
NVDA
$215.16
+1.7%
+$3.66
Arrow-Thin-Down
TSLA
$427.99
+3.9%
+$16.20
Most Active StocksDaily Stock GainersDaily Stock Losers
Life Stem Genetics logo

Life Stem Genetics

(OTC) LIFS

Current Price$0.00
Market Cap$24,600
Since IPO (2013)-100%
5 Year-98%
1 Year+0%
1 Month-67%

Life Stem Genetics Financials at a Glance

Market Cap

$24,600

Revenue (TTM)

$0.00

Net Income (TTM)

$11.13K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-6.24 (Low)

Price

$0.00

Volume

3,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

LIFS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Life Stem Genetics

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

1

CEO

Xin Shi

Website

www.lifestemgenetics.com

Headquarters

East Stroudsburg, NV, US

LIFS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

0%

Return on Assets

0%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.60K

Shares Outstanding

245.84M

Volume

3.00K

Avg. Volume

359.064

Financials (TTM)

Gross Profit

$0.00

Operating Income

$10.54K

EBITDA

$10.54K

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Life Stem Genetics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$24.60K

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$300.00

+87.0%

EBITDA

$300.00

+87.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TRVNTrevena, Inc.
$0.01+0.00%
CGHCCapital Group Holdings, Inc.
$0.00+0.00%
INFIQInfinity Pharmaceuticals, Inc.
$0.00+0.00%
ARDSAridis Pharmaceuticals, Inc.
$0.00-93.44%

Trending Stocks

Symbol / CompanyPricePrice Chg
RXTRackspace Technology
$5.49+0.56%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.62+0.08%
IRENIren
$61.20+0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$76.28+0.07%

Questions About LIFS

What is the current price of Life Stem Genetics?

Life Stem Genetics is trading at $0.00 per share.

What is the 52-week range for Life Stem Genetics?

Over the past 52 weeks, Life Stem Genetics has traded between $0.00 and $0.00.

How much debt does Life Stem Genetics have?

As of the most recent reporting period, Life Stem Genetics reported total debt of N/A.

How much cash does Life Stem Genetics have on hand?

Life Stem Genetics reported N/A in cash and cash equivalents in its most recent financial results.

What is Life Stem Genetics’s dividend yield?

Life Stem Genetics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services